Published

Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference

Summary by The Chandler Arizonan
HAYWARD, Calif., Nov. 11, 2024 /PRNewswire/ -- Avirmax's Chief Executive and Scientific Officer, Dr. Shengjiang Shawn Liu, Ph.D., will chair the upcoming session of "Acceleration of AAV Gene Therapy for Ocular Diseases: Improving Delivery and Quality, at the Virtual Frontiers…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)